BioCryst Pharmaceuticals shares owned by Mackenzie Financial
Quarter-by-quarter ownership of BioCryst Pharmaceuticals (BCRX) shares owned by Mackenzie Financial
from 13F filings
Historical chart of Mackenzie Financial investment in BioCryst Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including BioCryst Pharmaceuticals held by Mackenzie Financial consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in BioCryst Pharmaceuticals by Mackenzie Financial
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-09-30 | $221k | 29k | 7.60 |
2024-06-30 | $173k | 28k | 6.18 |
2024-03-31 | $164k | 32k | 5.08 |
2023-12-31 | $140k | 23k | 5.99 |
2023-09-30 | $86k | 13k | 6.42 |
2023-06-30 | $367k | 52k | 7.05 |
2023-03-31 | $491k | 59k | 8.34 |
2022-12-31 | $245k | 21k | 11.48 |
2022-09-30 | $663k | 53k | 12.61 |
2022-06-30 | $250k | 24k | 10.57 |
2022-03-31 | $290k | 18k | 16.29 |
2021-09-30 | $150k | 10k | 14.39 |